Concepedia

Helen X. Chen

HX

12

Publications

360

Citations

11

H-Index

2001

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

National Cancer Institute

Brigham and Women's Hospital

Harvard University

National Institutes of Health

Helen X. Chen is an author at Dana-Farber Cancer Institute specializing in medicine, lung cancer, and radiation oncology.

ORCID

Top concepts

Publications per year

2001–2024

12

Publications

12

A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer

Arta M. Monjazeb, Anita Giobbie‐Hurder, Ana Lako et al. · Clinical Cancer Research · 2021 · 98 citations · Full text

Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease

Livius Penter, Yang Liu, Jacquelyn O. Wolff et al. · Blood · 2023 · 48 citations · Full text

, , +20

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer

Wu-Wei Lai, Fen-Fen Chen, Ming-Ho Wu et al. · The Annals of Thoracic Surgery · 2001 · 37 citations

, , +9

Differential Outcomes in Codon 12/13 and Codon 61 <i>NRAS</i> -Mutated Cancers in the Phase II NCI-MATCH Trial of Binimetinib in Patients with <i>NRAS</i> -Mutated Tumors

James M. Cleary, Victoria Wang, Rebecca S. Heist et al. · Clinical Cancer Research · 2021 · 35 citations · Full text

Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors

Ryan B. Corcoran, T. Khanh, Jeong Eun Kim et al. · Clinical Cancer Research · 2024 · 31 citations · Full text

Rows per page

1–5 of 12